Acomplia (rimonabant) suspended across the EU.
October 30th, 2008 by 
Eric
FirstMed has placed a hold on supplying the weight loss treatment Acomplia because of new research.
The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CMHP) has announced the suspension of the diet pill, Acomplia. The most recent assessment by the CHMP showed that there was approximately a doubling of the risk of psychiatric disorders in obese or overweight patients taking Acomplia compared to those taking a placebo (a dummy pill).
Advice for patients
Patients currently taking Acomplia should consult their doctor or pharmacist when convenient to discuss their treatment. Patients who wish to stop taking Acomplia can do so at any time.
Advice for healthcare professionals
Prescribers should not issue any prescriptions for Acomplia and should review the treatment of patients currently taking the medicine. A letter is being sent to healthcare professionals about this announcement, through the Department of Health’s Central Alerting System.
Posted in Weight loss, News, Research, Diets | 